MetLife Investment Management LLC lowered its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Free Report) by 0.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 257,549 shares of the real estate investment trust’s stock after selling 739 shares during the period. MetLife Investment Management LLC owned approximately 0.11% of Sabra Health Care REIT worth $4,793,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also modified their holdings of the company. Family Firm Inc. purchased a new stake in Sabra Health Care REIT in the 2nd quarter worth about $26,000. Assetmark Inc. increased its holdings in shares of Sabra Health Care REIT by 168.4% in the 3rd quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust’s stock valued at $37,000 after purchasing an additional 1,231 shares during the period. GAMMA Investing LLC lifted its position in shares of Sabra Health Care REIT by 40.0% in the second quarter. GAMMA Investing LLC now owns 3,682 shares of the real estate investment trust’s stock worth $57,000 after purchasing an additional 1,052 shares in the last quarter. Harbor Capital Advisors Inc. acquired a new stake in shares of Sabra Health Care REIT during the third quarter worth approximately $78,000. Finally, International Assets Investment Management LLC grew its position in Sabra Health Care REIT by 1,761.0% during the third quarter. International Assets Investment Management LLC now owns 6,104 shares of the real estate investment trust’s stock valued at $114,000 after purchasing an additional 5,776 shares in the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.
Analyst Ratings Changes
A number of research firms have issued reports on SBRA. Truist Financial increased their target price on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Citigroup upgraded Sabra Health Care REIT from a “neutral” rating to a “buy” rating and boosted their target price for the company from $17.00 to $20.00 in a research note on Friday, September 13th. Wells Fargo & Company raised Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $16.00 to $20.00 in a research note on Tuesday, October 1st. Finally, Scotiabank boosted their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research note on Friday, October 11th. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $18.71.
Sabra Health Care REIT Stock Performance
Shares of NASDAQ SBRA opened at $18.73 on Monday. The business’s 50-day simple moving average is $18.64 and its 200-day simple moving average is $16.84. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.16 and a current ratio of 4.16. Sabra Health Care REIT, Inc. has a 52 week low of $12.83 and a 52 week high of $20.03. The firm has a market cap of $4.43 billion, a price-to-earnings ratio of 45.68, a P/E/G ratio of 2.35 and a beta of 1.25.
Sabra Health Care REIT (NASDAQ:SBRA – Get Free Report) last announced its quarterly earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.22). The company had revenue of $178.00 million for the quarter, compared to analyst estimates of $177.19 million. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. During the same quarter last year, the business earned $0.34 EPS. As a group, equities research analysts expect that Sabra Health Care REIT, Inc. will post 1.39 earnings per share for the current fiscal year.
Sabra Health Care REIT Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.41%. The ex-dividend date of this dividend was Friday, November 15th. Sabra Health Care REIT’s dividend payout ratio is currently 292.69%.
About Sabra Health Care REIT
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
Recommended Stories
- Five stocks we like better than Sabra Health Care REIT
- 3 Small Caps With Big Return Potential
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- How to Invest in the Best Canadian StocksĀ
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- Investing in Construction Stocks
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.